QURE · uniQure N.V.
AI read · Neutral
The AI's read
The FDA accepted the 36-month data as the main support for uniQure's application. That gives the company a route to seek approval. But at 48 months, one key measure did not clearly rule out chance, and many control patients were missing. A later analysis using older control data found significant slowing, so the longer-term findings point in different directions.